Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are ...

Thank you for standing by for the Cigna Group's fourth quarter 2024 results review. At this time, all callers are in a listen ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Management projects 2025 adjusted EPS of at least $29.50, supported by biosimilar growth and strategic investments. Full-year consolidated adjusted revenue is expected to exceed $252 billion.

Express Scripts aims to ensure that patients directly benefit from its negotiations with drug manufacturers. The new approach will protect patients from paying inflated list prices for medications, ...

Deep-pocketed investors have adopted a bullish approach towards Cigna CI, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Cigna (CI) stock falls as the managed care company's Q4 2024 earnings miss the consensus due to an unexpected rise in medical ...

Cigna Healthcare and Providence are expanding their Los Angeles County network, offering customers several additional care ...